Browsing by Author "d3e13701-06e5-45b7-9e83-bb32eb678ed6"

Now showing items 1-4 of 4

    • Diabetes Mellitus-Associated Uveitis: Clinical Features in a Chilean Series 
      Sabat Opazo, Pablo; Anguita Henríquez, Rodrigo; Sáez Vergara, Víctor; Morales Estupiñan, Sergio; Urzúa Salinas, Cristhian; Villarroel, Francisco; Velásquez Rojas, Víctor (Taylor & Francis, 2020)
      Purpose: To describe clinical features of patients with diabetes mellitus-associated uveitis (DMAU). Methods: Retrospective analysis of clinical records of patients with uveitis and diabetes mellitus (DM) presented in ...
    • Effectiveness of infliximab in patients with Behçet syndrome and severe uveoretinitis. Report of five cases ... 
      Merino, Guillermo; Varas, Gonzalo; Estay Díaz, Gonzalo; Gutiérrez, Miguel; Massardo, Loreto; Pacheco, Daniel; Villarroel, Francisco; Cuchacovich, Miguel (2006)
      The efficacy and safety of repeated administration of infliximab was evaluated in five patients (two men, three women) with Behçet syndrome accompanied by severe uveoretinitis. Ocular and extra ocular inflammation was ...
    • Retrospective review of 44 Chilean patients with Behçet disease Enfermedad de Behçet en Chile: Análisis ... 
      Wurmann, Pamela; Estay Díaz, Gonzalo; Sabugo, Francisca; Soto, Lilian; Solanes, Federica; Pino, Sandra; Merino, Guillermo; Verdaguer, Juan Ignacio; Villarroel, Francisco; Cuchacovich, Miguel (2009)
      Background: Behçet's disease (BD) is a rare multisystemic inflammatory disease that is potentially disabling and may cause death. Aim: To describe the characteristics of BD patients from two Chilean centers. Patients and ...
    • Role of Azathioprine in steroid resistant non infectious ocular inflammatory diseases Eficacia de la ... 
      Cuchacovich, Miguel; Pacheco, Patricio; Estay Díaz, Gonzalo; Rojas, Basilio; Stoppel, Juan; Merino, Guillermo; Verdaguer, Juan Ignacio; Verdaguer, Juan; Villarroel, Francisco (2007)
      Background: Topical and systemic steroids are the first line of treatment of non infectious inflammatory ocular disease. Immunosuppresants are reserved as a second line treatment. Aim: To evaluate the role of Azathioprine ...